Log In
BCIQ
Print this Print this
 

GRI-0621

  Manage Alerts
Collapse Summary General Information
Company GRI Bio Inc.
DescriptionInhibitor of type I natural killer T cells
Molecular Target Natural killer T cells
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today